Outcomes of COVID-19 and Vaccination in Patients With Moderate to Severe Atopic Dermatitis Treated With Tralokinumab
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Dermatology"
DOI: 10.1001/jamadermatol.2022.3488
Abstract: This case series describes the outcomes of COVID-19 and SARS-CoV-2 vaccination in patients with atopic dermatitis who have been treated with tralokinumab. read more here.
Keywords: vaccination patients; treated tralokinumab; atopic dermatitis; dermatitis treated ... See more keywords
Recommendations for Vaccination in Children with Atopic Dermatitis Treated with Dupilumab: A Consensus Meeting, 2020
Sign Up to like & getrecommendations! Published in 2021 at "American Journal of Clinical Dermatology"
DOI: 10.1007/s40257-021-00607-6
Abstract: Dupilumab is the only biologic therapy currently approved in Europe and the United States for severe atopic dermatitis in patients 6 years of age or older. Off-label use is rationalized in younger children with severe… read more here.
Keywords: dermatology; atopic dermatitis; dermatitis treated; vaccination children ... See more keywords